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Abstract
Purpose Clinical application of narrow band imaging facil-
itates diagnosis of esophageal neoplasia. However, no pre-
vious investigation has been conducted on magnifying
endoscopy combined with narrow band imaging in detec-
tion of minimal superficial esophageal neoplasia, which is
defined as neoplasia <10 mm in diameter. The aim of this
retrospective study was to evaluate the usefulness of this
combined technique in the differential diagnosis of minimal
superficial esophageal neoplasia.
Methods Between January 2005 and November 2011, 53
minimal superficial esophageal neoplasias in 40 patients
were diagnosed by screening upper gastrointestinal endos-
copy with narrow band imaging at our hospital. We inves-
tigated findings including brownish dots, brownish
epithelium, and demarcation line of minimal superficial
esophageal neoplasia diagnosed histopathologically as
low-grade intraepithelial neoplasia, high-grade intraepithelial
neoplasia, and squamous cell carcinoma.
Results Significantly more brownish dots (P<0.05) and
brownish epithelium (P<0.005) were observed in intraepi-
thelial papillary capillary loops in high-grade neoplasia
compared with low-grade neoplasia. When minimal super-
ficial esophageal neoplasia was diagnosed as high-grade
intraepithelial neoplasia or squamous cell carcinoma, sensi-
tivity, specificity, positive predictive value, and negative
predictive value were 88.9, 42.9, 44.4, and 88.2 %, respec-
tively, for brownish dots; 94.4, 51.4, 50.0, and 94.7 %,
respectively, for brownish epithelium; and 66.7, 62.9, 48.0,
and 78.6 %, respectively, for demarcation line.
Conclusions The combined technique was useful in the differ-
ential diagnosis of minimal superficial esophageal neoplasia.
Keywords Endoscopy . Esophageal neoplasms .
Carcinoma . Squamous cell carcinoma . Narrow band
imaging . Magnifying endoscopy
Introduction
Esophageal cancer is the sixth largest cause of cancer-
related death and has poor prognosis [1]. Treatment of
Y. Mochizuki (*) :Y. Saito
Division of Digestive Endoscopy,




A. Kobori :H. Ban :M. Shioya : T. Nishimura :O. Inatomi :
S. Bamba :Y. Fujiyama
Department of Medicine, Shiga University of Medical Science,
Ōtsu, Japan
T. Tsujikawa
Division of Comprehensive Internal Medicine,
Shiga University of Medical Science,
Ōtsu, Japan
M. Ishida
Department of Clinical Laboratory Medicine,
Shiga University of Medical Science,
Ōtsu, Japan
A. Andoh
Division of Mucosal Immunology, Graduate School of Medicine,
Shiga University of Medical Science,
Ōtsu, Japan
J Gastrointest Canc (2012) 43:599–606
DOI 10.1007/s12029-012-9395-0
esophageal cancer depends on the depth of cancer invasion,
which reflects the risk of metastasis. Superficial esoph-
ageal cancer is defined as that with mucosal or submu-
cosal invasion. Because of the low risk of lymph node
metastasis in this type of cancer, endoscopic mucosal
resection (EMR) has been established as a standard
therapeutic approach for superficial esophageal squa-
mous cell carcinoma (ESCC) within the lamina propria
mucosa (LPM) [2–6]. Recent advances in endoscopic
techniques for treating gastrointestinal tumor include
endoscopic submucosal dissection, in which extensive
lesions can be excised en bloc for ESCC. This tech-
nique has also become prevalent for treating stomach
and colon cancer [7–10].
The risk of lymph node metastasis in esophageal
cancer varies by the degree of depth. For example,
Kodama and Kakegawa revealed an increasing rate of
lymph node metastasis in superficial ESCC according to
the following infiltration level: 0 % in the epithelium,
3.3 % in the LPM, 12.2 % in the muscularis mucosa,
26.5 % in the upper submucosal third, 35.8 % in the
middle submucosal third, and as high as 45.9 % in the
lower submucosal third [4]. From the viewpoint of the
risk of lymph node metastasis, early detection of ESCC
is vital.
Previous reports have demonstrated the usefulness of
endoscopic screening combined with iodine staining in
the identification of esophageal cancer [11, 12]. In re-
cent years, narrow band imaging (NBI) combined with
magnifying endoscopy (ME), a technique developed by
Olympus Optical Co., Ltd., Tokyo, Japan, has created a new
diagnostics method that involves observing capillaries and
fine tissue structures. Clinical application of this combined
technique (ME-NBI) facilitates diagnosis of esophageal neo-
plasia and diagnostic accuracy of invasion depth [13–18].
Morphological changes in the intraepithelial papillary capil-
lary loop (IPCL) are important in the diagnosis of ESCC.
Visualizing these changes by ME-NBI has been reported to
contribute to the diagnosis of depth of invasion [19]. NBI
clearly identifies esophageal epithelial tumor as a
brownish lesion, and it is considered superior to iodine
staining. It improves detection of neoplastic lesions of
the esophagus in screening endoscopy even without
ME. However, the combination of these two techniques
holds promise for future clinical applications. NBI is
expected to be widely used in future diagnoses of
esophageal cancer. However, just as the treatment of
small lugol voided lesions is completely unknown, there
is no consensus for treatment of small lesions identified
as brownish areas on NBI. The aim of this study is to evaluate
the ability of ME-NBI to distinguish lesions <10 mm in




Our retrospective investigation examined 53 MSEN
lesions <10 mm in diameter in terms of tumor size,
location, morphology, use of ME-NBI, and histopatho-
logical findings. These lesions were diagnosed by
screening upper gastrointestinal endoscopy with NBI in
40 patients and were resected by EMR at our hospital
from January 2005 to November 2011.
EMR Methods
EMR was performed under sedation by periodic intravenous
administration of midazolam (0.05–0.1 mg/kg) and propofol
(2 mg/kg/h) while monitoring blood pressure, heart rate, and
blood oxygen saturation. The following endoscopes were
used: GIF-Q240, GIF-Q240Z, GIF-Q260Z, GIF-H260, and
GIF-Q260J (Olympus Optical Co., Ltd., Tokyo, Japan).
After the lesion was confirmed by NBI, the oral and anal
sides of the lesion were marked using a needle knife and
high-frequency devices (VIO300D; ERBE, Elektromedizin
GmbH, Germany). After local injection of saline into the
submucosal layer, the lesion was aspirated through the end
cap attached to the endoscope. Subsequently, the aspirated
lesion was removed using the snare EMR method in the
Endocut mode of the high-frequency device. To control
bleeding from exposed vessels or the ulcer site after resection,
hemostatic treatment using a hemostatic forceps was admin-
istered (FD-410LR; Olympus) by the soft coagulation mode.
Endoscopic Findings
We did not perform iodine staining or biopsy in the diagno-
sis of 53 MSENs before EMR in this study. ME-NBI of the
53 MSENs revealed brownish dots, brownish epithelium,
and demarcation line. Brownish dots indicated dilated,
extended, and tortuous IPCL with caliber variation and
dilation. Epithelium was recognized as the brownish area
in each IPCL. Demarcation line was observed as uniformly
distributed brownish epithelium over the area of brownish
dots. The absence of demarcation line was indicated by no
or only partially visible brownish epithelium, or nonuniform
distribution of brownish epithelium in the area of brownish
dots, as shown in Fig. 1.
The endoscopists who examined ME-NBI were not blind
to clinical details of all patients. Intraobserver agreement
was evaluated at 1-month intervals and interobserver agree-
ment was evaluated between two experienced endoscopists
(Y.M. and Y.S.) who both had used the NBI system for more
than 5 years. They were blind to the patients’ final clinical
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information and histological results of the lesions. Intra- and
interobserver agreement were assessed by kappa statistics.
Pathological Examination
The resected samples were diagnosed by hematoxylin–eosin
staining. Only one pathologist in our hospital diagnosed all
the lesions using an electron microscope and classified the
lesions according to the World Health Organization classi-
fication [19]. Histopathological type [low-grade intraepithe-
lial neoplasia (LGIN), high-grade intraepithelial neoplasia
(HGIN), and squamous cell carcinoma (SCC)], depth of inva-
sion, lateral and vertical resection margin, and level of lym-
phovascular involvement were microscopically evaluated.
Results
The characteristics (age, sex, smoking, and drinking habits)
of patients who underwent EMR in this study are shown in
Table 1. Mean age of the 40 patients was 69.5 years (range
51–80) and the male to female ratio was 34:6. Smoking
habits were measured by the Brinkman index (number of
cigarettes smoked per day×number of years of smoking),
and drinking habits were shown by average daily amount of
alcohol intake (gram). The average Brinkman index score
was 880 (range 0–3,360). The average daily amount of
alcohol intake was 61 g (range 0–292). All 53 lesions in
this study were excised by EMR. No complications such as
perforation and bleeding were observed. All lesions had
negative surgical margins. No lymphatic or vascular inva-
sion was evident. No recurrence has been observed to date.
Histopathological examination identified six lesions
(11.3 %) as SCC in the LPM. Other classifications were as
follows: 47 lesions (88.7 %) were intraepithelial neoplasias,
35 (66.0 %) were LGIN, and 12 (22.6 %) were HGIN. No
inflammation or other neoplastic lesions were observed.
Characteristics (tumor size, localization, morphology) of
the resected lesions are shown in Table 2 for the three
groups: LGIN, HGIN, and SCC. Average tumor sizes in
the LGIN, HGIN, and SCC groups were 3.1, 5.4, and
7.2 mm, respectively. Localization of tumors was as follows:
upper: 14, middle: 20, lower: 1 for LGIN; upper: 3, middle: 8,
lower: 1 for HGIN; and upper: 2, middle: 2, lower: 2 for SCC.
All 53 lesions appeared as brownish areas on ME-NBI. Mor-
phologically, four lesions (HGIN—two, SCC—two) were
slightly depressed and the other 49 lesions were all flat type.
P values of <0.05 on two-tailed Welch’s t test were con-
sidered statistically significant. HGIN was significantly
Fig. 1 a Presence of demarcation line: uniform distribution of brown-
ish epithelium (arrow) over the entire lesion in the presence of brown-
ish dots (arrowhead). b Absence of demarcation line: no brownish
epithelium. c Absence of demarcation line: partial distribution of
brownish epithelium in the presence of brownish dots. d Absence of
demarcation line: nonuniform distribution of brownish epithelium over
the entire lesion
Table 1 Baseline char-
acteristics of patients
Smoking habit was
shown by Brinkman in-
dex (number of ciga-
rettes smoked per day×
smoking years), and
drinking habit shown by








Median (range) 880 (0–3,360)
Daily alcohol intake (g)
Median (range) 61 (0–292)
Table 2 Characteristics of the endoscopically resected small esopha-
geal lesions
LGIN (n035) HGIN (n012) SCC (n06)
Tumor size (mm)
Mean (SD) 3.1 (1.8) 5.4 (2.3)* 7.2 (2.5)**
Tumor location
Upper 14 3 2
Middle 20 8 2
Lower 1 1 2
Tumor morphology
0-IIa 0 0 0
0-IIb 35 10 4
0-IIc 0 2 2
LGIN low-grade intraepithelial neoplasia, HGIN high-grade intraepi-
thelial neoplasia, SCC squamous cell carcinoma, 0-IIa slightly elevated
type, 0-IIb flat type, 0-IIc slightly depressed type
*P<0.05; **P<0.005: P value was calculated as comparisons between
LGIN, HGIN, LGIN, and SCC
J Gastrointest Canc (2012) 43:599–606 601
greater than LGIN (P00.0039). SCC was also significantly
greater than LGIN (P00.015).
Results of ME-NBI for MSEN in this study are shown in
Table 3. P values of <0.05 in two-tailed Fisher’s exact test
were considered statistically significant. Significantly more
brownish dots and brownish epithelium were observed in
HGIN compared with LGIN (P00.037 and P00.0014,
respectively). No significant difference in demarcation line
was observed between the three groups.
As shown in Fig. 1, a demarcation line was observed as a
uniform distribution of brownish epithelium over the entire
area of brownish dots. The absence of a demarcation line
was indicated when brownish epithelium was not visible or
only partially visible, or distribution of brownish epithelium
in the area of brownish dots was not uniform. Lesions
without a demarcation line were found in all three groups
as follows: LGIN (n04), HGIN (n05), and SCC (n01).
When MSEN was diagnosed as HGIN or SCC, sensitivity,
specificity, positive predictive value, and negative predictive
value were 88.9, 42.9, 44.4, and 88.2 %, respectively, for
brownish dots; 94.4, 51.4, 50.0, and 94.7 %, respectively,
for brownish epithelium; and 66.7, 62.9, 48.0, and 78.6 %,
respectively, for demarcation line (Table 4).
Intraobserver agreement (κ value) of brownish dots,
brownish epithelium, and demarcation line was 0.78, 0.72,
and 0.61, respectively, which indicated substantial agree-
ment. Interobserver agreement (κ value) of brownish dots,
brownish epithelium, and demarcation line was 0.58, 0.52,
and 0.41, respectively, which indicated moderate agreement.
Endoscopic and histopathological findings in patients
with typical LGIN, HGIN, and SCC diagnosed by NBI are
shown in Figs. 2, 3, and 4, respectively.
Figure 2 shows the case of a 66-year-old woman with a
flat reddened area 2 mm in diameter at the upper esophagus
visible by conventional endoscopy with white light (Fig. 2a
arrow). The lesion appeared as a brownish area on NBI
(Fig. 2b arrow) and was diagnosed as esophageal epithelial
neoplasia with enlarged and tortuous IPCL by ME-NBI
(Fig. 2c). After EMR, histopathological examination of the
resected lesion led to a diagnosis of LGIN (Fig. 2d) because
neoplastic cells with atypical nuclei and prominent nucleoli
were present in <50 % of the thickness of the epithelium.
Figure 3 shows the case of a 65-year-old woman with a
flat reddened area 2 mm in diameter in the middle esophagus
visible by conventional endoscopy with white light (Fig. 3a
arrow). The lesion appeared as a brownish area on NBI
(Fig. 3b arrow) and was diagnosed as esophageal epithelial
neoplasia with dilated, enlarged, and tortuous IPCL and
brownish epithelium by ME-NBI (Fig. 3c). After EMR,
histopathological examination of the resected lesion led to a
diagnosis of HGIN (Fig. 3d) because neoplastic cells with
atypical nuclei and prominent nucleoli were present in >50 %
of the thickness of the epithelium.
Figure 4 shows the case of a 79-year-old man with a flat
reddened area 9 mm in diameter with poor diaphanous
vessels at the lower esophagus visible by conventional
endoscopy with white light (Fig. 4a arrow). The lesion
appeared as a well-demarcated brownish area on NBI
Table 3 NBI findings in small
esophageal lesions
P value of <0.05 was considered
statistically significant (two-





LGIN (n035) HGIN (n012) SCC (n06) P value
Brownish dots 0.037
Positive 20 11 5
Negative 15 1 1
Brownish epithelium 0.0014
Positive 17 12 5
Negative 18 0 1
Demarcation line
Positive 13 7 5
Negative 22 5 1
Table 4 Sensitivity, specificity, and predictive values of NBI findings in small esophageal lesions, when MSEN was diagnosed as high-grade
intraepithelial neoplasia or squamous cell carcinoma
Sensitivity (%) Specificity (%) PPV (%) NPV (%)
Brownish dots 88.9 42.9 44.4 88.2
Brownish epithelium 94.4 51.4 50 94.7
Demarcation line 66.7 62.9 48 78.6
PPV positive predictive value, NPV negative predictive value, MSEN minimal superficial esophageal neoplasia
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(Fig. 4b arrow) and was diagnosed as esophageal epithelial
neoplasia with dilated, enlarged, and tortuous IPCL with
caliber variation on ME-NBI (Fig. 4c). After EMR, patho-
logical examination of the resected lesion led to a diagnosis
of SCC because neoplastic cells were present throughout the
epithelium and invaded the LPM with negative lateral mar-
gins and without lymphatic and vascular invasion (Fig. 4d).
Discussion
NBI is an optical technique that is implemented by dedicated
CLV-260SL or CV-260SL source units (Olympus Optical Co.,
Ltd., Tokyo, Japan). There are many different scopes avail-
able. Using an optical filter, NBI utilizes the absorption char-
acteristics of hemoglobin, generating light in two narrow
Fig. 2 a A case of LGIN. Note
the flat reddened area 2 mm in
diameter on white light in the
upper esophagus (arrow). b
Brownish area on NBI (arrow).
c Extended IPCL visible by
ME-NBI. d Resected specimen
of LGIN. Neoplastic cells with
atypical nuclei and prominent
nucleoli are present in <50 % of
the thickness of the epithelium
(hematoxylin and eosin stain)
Fig. 3 a A case of HGIN. Note
the flat reddened area 2 mm in
diameter on white light in the
middle esophagus (arrow). b
Brownish area on NBI (arrow).
c Dilated, extended, and
tortuous IPCL with brownish
epithelium visible by ME-NBI.
d Resected specimen of HGIN.
Neoplastic cells with atypical
nuclei and prominent nucleoli
in >50 % of the thickness of the
epithelium (hematoxylin and
eosin stain)
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bands of 540 and 415 nm. Hemoglobin strongly absorbs these
wavelengths. Light of these wavelengths is suitable for visu-
alizing the microvessels and microstructure of gastrointestinal
mucosa. The light is propagated at different depths in the
mucosal tissues, which enables detailed description of blood
vessel morphology. The 415-nm narrow band of light depicts
surface vessels of the mucosa as brown, and the 540-nm
narrow band depicts subepithelial vessels as cyan. The color
difference enables definitive representation of microvessels on
images.
Conventionally, iodine staining is useful in the diagnosis
of esophageal cancer [11], but it presents certain problems.
Iodine irritates the esophagus, and considerable effort is
necessary to insert the spray tube. In contrast, NBI is an
optical image enhancement technology that features a sim-
ple one-touch system and can be performed without irrita-
tion to the esophagus or the hassle of dye spray. One report
indicated no difference between NBI and iodine staining in
the diagnosis of HGIN [20]. In the series reported here, NBI
was clinically easy to perform and more useful than iodine
staining. Therefore, in screening endoscopy in our hospital,
NBI has been used more frequently than iodine staining, and
it is now a standard procedure in almost all cases since its
introduction.
Morphology if MSENs <10 mm in diameter included in
this study was mostly flat. These small MSENs were gen-
erally recognized by their slightly red color on conventional
endoscopy with white light. However, they were more easily
recognized by their brownish color on NBI. Esophageal
epithelial tumors appear brownish on NBI and are identified
by crowding of dilated IPCL and brown epithelium between
IPCLs [21]. Thus, NBI enabled detection of very small esoph-
ageal lesions. Shimizu et al. reported that 0-IIb lesions <1 cm
in the largest diameter of the esophagus might be regarded as
intraepithelial neoplasia [22]. This was true in our study,
which was limited to lesions <10 mm in diameter. However,
although we examined esophageal epithelial tumors <10 mm,
SCC was also found (6/53, 11.3 %). Because small esopha-
geal lesions are sometimes also identified as SCC, we exam-
ined the diagnostic performance of ME-NBI, instead of the
ability of this combined technique to differentiate tumor size.
It is important to detect ESCC early, when it is small, to
facilitate early treatment. However, there has been some
debate as to whether it is really important to detect LGIN
or HGIN because of treatment difficulties. One report stated
that 30 % of lesions diagnosed as HGIN by biopsy had been
diagnosed pathologically as SCC after EMR [22]. Because
we have had similar experiences in our hospital, we consider
HGIN to be treatable.
In intraepithelial neoplasia of the esophagus, it is impor-
tant to discriminate between LGIN and HGIN. Muto et al.
argued that the brownish epithelium visible on NBI could
differentiate the boundaries to some extent in distinguishing
between LGIN and HGIN [21].
In the study of Ishihara et al., sensitivity and specificity in
diagnosing HGIN and SCC from brownish dots and brownish
epithelium visible on NBI were 85 and 79 %, respectively
[23]. According to their study, brownish dots and brownish
epithelium were significant NBI findings in esophageal squa-
mous mucosal high-grade neoplasia and demarcation line was
Fig. 4 a A case of SCC. Note
the flat reddened area 9 mm in
diameter with white light in the
lower esophagus (arrow). b
Brownish epithelium with
irregular borderline (arrow). c
Dilated and extended IPCL
with well-demarcated brownish
area visible by ME-NBI. d
Resected specimen of SCC.
Neoplastic cells are present
throughout the epithelium and
invade the LPM (hematoxylin
and eosin stain)
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not a statistically significant finding. But we also re-evaluated
demarcation line, because demarcation line was significantly
associated with the diagnosis of mucosal high-grade neoplasia
in univariate analysis by Ishihara et al., and we considered that
it could be a simple index in diagnosing HGIN and SCC by
redefining it as uniformly distributed brownish epithelium over
the area of brownish dots. The same trend of significantly more
brownish dots and brownish epithelium in HGIN and SCCwas
observed in this study of lesions <10 mm in diameter.
Considering the results of the combined technique in
terms of sensitivity, specificity, and predictive value, MSEN
with neither brownish dots nor brownish epithelium seemed
likely to be LGIN. In addition, ME-NBI of MSEN seemed
to be useful to some extent in distinguishing between lesions
that need to be treated, such as those classified as HGIN or
SCC, and LGIN lesions, which may not require immediate
treatment. In other words, ME-NBI was useful in determin-
ing indications for treatment of MSEN.
However, LGIN can develop to HGIN and SCC if left
untreated. Because even small lesions turn out to be HGIN
after resection, and lesions diagnosed as HGIN by NBI turn
out to be LGIN, we conclude that resection of LGIN in the
cases examined here was warranted. In this study, written
consent was obtained from all patients before EMR.
Detection of minimal LGIN and HGIN is very useful for
the following reasons: These types of neoplasias carry sig-
nificant risk of progression to SCC [24]. In addition, lugol
voiding lesions (LVLs), including intraepithelial neoplasias
of varying degrees, are an important risk factor for a second
primary SCC in patients with esophageal cancer or head and
neck cancer [25]. The larger the size of the unstained area by
iodine staining, the higher the frequency of HGIN and
carcinoma in situ than LGIN [26]. The presence of multiple
LVLs in patients with head and neck cancer is an indepen-
dent risk factor for multifocal ESCC [27].
As with multiple LVLs detected by iodine staining,
detecting multiple LGINs and HGINs of smaller size by
NBI and identifying risk factors in the development of
SCC is clinically useful. However, different levels of expe-
rience with NBI may lead to significant differences in lesion
detection [28]. Thus, sufficient training is needed.
In conclusion, NBI combined with ME contributed to
accurate detection of MSEN. ME-NBI enabled differential
diagnosis of MSEN. Limitations of this study included its
single-center, retrospective nature, and small number of
cases. There was also variation in endoscope selection and
skill level of the operators.
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